Right now someone, somewhere, is chatting with an AI algorithm asking, “what GLP-1 medication should I use?” Perhaps this person has heard of the correlation between GLP-1 use and modulated addictive behavior. Or, conversely, this person could be asking, “How can I get off GLP-1? And if I get off it, will my appetite or addictive behaviors come roaring back?”

It is easy to imagine the appeal of AI chatbot conversations concerning GLP-1 usage and cessation. No waiting to speak to a doctor or clinician, or fear that you’ll receive a hefty healthcare bill, because the fee associated with a chatbot maxes out at your monthly AI subscription cost. You get advice in plain language and ask as many additional questions as you want. Plus, the chat is (supposedly) private, though by default your inputs are feeding back into AI training regardless of the model you use. 

A new study from Nature Health looks at new risks generative AI presents, and it should be of interest to anyone with health or addiction queries. The first risk is inaccurate guidance. AI chatbot inaccuracies continue to be blamed for the deaths of people seeking guidance on illicit substances or in lieu of medical care while tapering a prescription medication, to name just two examples.  

The second risk is largely invisible. In the words of the study: “Malicious actors can now generate personalized health misinformation at negligible cost.” At scale. 

Let’s imagine what that could look like. Perhaps a devious company floods the internet with health claims associated with a product only they sell. Once online, that information is vacuumed up, along with everything else, into AI models. Presto! The AI may suggest this product to you next time you chat. Is that product actually good for you? Who knows! It is good for sales.

Write the authors:

In this Perspective, we argue that these risks are largely invisible to the institutions responsible for protecting public health. When AI guidance causes harm, no record exists outside the platform, no channel allows users to report it and no independent researcher can measure the consequences. We trace these invisible risks across two settings: incidental exposure online and active seeking through search engines and chatbots.

AI chatbot advice about GLP-1 medications is an area ripe for malicious intent given Americans’ increasing use of both technologies. 

To wit, Americans’ use of GLP-1 injectables for weight loss has nearly quadrupled since 2024. That figure doesn’t include newer, tablet versions or off-brand variations produced by compounding pharmacies. Nor does it account for the ongoing rise in cultural adoption and use. Sales continue to rise.

Concurrently, about a quarter of Americans report using an AI chatbot every day, with overall usage up substantially from the summer of 2024. Bill Gates is sounding the alarm that, among other things, the effects of this heavy use on mental health. Chatbot addiction is a risk, which is ironic because some tools to fight addiction are built on top of the tech.

Now add in nefarious actors chasing both of these massive trends (AI, GLP-1). It would be sensible from their point of view to develop something that looks and acts like a chatbot but is really a method to steal money or data from you. Or, given the widespread use, develop something as a way to mess with you “for the lulz” (noting, dear reader, they would not describe their behavior as “for the lulz” given that slang is embarrassingly pegged to 2008. But I’m sure you get the point). Bad actors don’t need good reasons. They just need good trends at scale.

People seeking answers to GLP-1 medication use or cessation — or any other topic — should be careful if they bring an AI chatbot into the mix. At potential risk are personal privacy or mental health. Or, relying too much on AI may itself introduce addictive behavior. Given the rise of both GLP-1s and AI use, searching the combination could even introduce unexpected cybersecurity vulnerabilities. Proceed with care.

Written by Katie McCaskey. First published November 10, 2026.

Sources:

“The invisible risks of AI-generated health information,” Nature Health, October 9, 2026.

“Study exposes privacy risks of AI chatbot conversations,” Stanford Report, October 15, 2025.

“‘Will I be OK?’ Teen died after ChatGPT pushed deadly mix of drugs, lawsuit says,” Ars Technica, May 12, 2026.

“Parents sue OpenAI, alleging GPT-4o coached their daughter off seizure medication,” TechCrunch, accessed November 4, 2026.

“In U.S., GLP-1 Usage Reaches New High,” Gallup, updated September 8, 2026.

“Americans and AI 2026: Chatbots, Smart Devices and Views on Impact,” Pew Research Center, June 17, 2026.

“Lulz,” Give Up, Internet! Accessed November 4, 2026.

Image Copyright: oohphoto.